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Available online 11 March 2008The 37 kDa/67 kDa laminin receptor LRP/LR acts as a receptor for both PrPc and PrPSc at the cell surface. Here,
we further analyzed the subcellular localization of ﬂuorescent labeled prion protein (PrP) and laminin
receptor (LRP/LR) molecules. We show that EGFP-PrP is localized at the cell surface and in a perinuclear
compartment, respectively. In contrast, a DsRed-ΔSP-PrP mutant lacking the signal peptide is almost
exclusively found in the nucleus but does not colocalize with heterochromatin. Interestingly, LRP-DsRed
efﬁciently colocalizes with EGFP-PrP in the perinuclear compartment and LRP-ECFP partly colocalizes with
DsRed-ΔSP-PrP in the nucleus, respectively. We conclude that the interactions of PrP and LRP/LR are not
restricted to the cell surface but occur also in intracellular compartments suggesting a putative role of LRP/LR
in the trafﬁcking of PrP molecules.
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The cellular prion protein PrPc is one of the most studied proteins
in eukaryotic cell biology, because it is not only the central player
in prion diseases but it unraveled how an infectious agent could
consist of protein only. The so-called protein-only hypothesis, which
was formulated by Stanley B. Prusiner in 1982 [1] is nowadays well-
grounded on recent studies [2,3]. However, it still remains an open
task to determine the function of PrPc, because Prnp knock-out mice
showed no obvious phenotype [4]. There exist a tremendous number
of postulated functions for PrPc [5–11] including copper binding,
signal transduction, neuroprotection and oxidative stress reactions.
Previously, a green ﬂuorescent protein coupled PrPc has been used
in many studies for subcellular visualization of the protein [12–16]. In
living cells, immunoﬂuorescent studies showed an equal localization
pattern compared to endogenous PrP [17]. Interestingly, a mutant
version of PrPc lacking its signal peptide translocates the protein from
the endoplasmatic reticulum to the nucleus [18]. However, the ﬁnding
cannot be explained by the presence of nuclear localization signals
within the protein sequence [18]. Since PrPc has RNA bindingochemie der LMU München,
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l rights reserved.properties [19], the nuclear localization of truncated PrPc may be of
physiological relevance.
The 37 kDa/67 kDa laminin receptor (LRP/LR) plays a major role
within the cellular functions of PrPc. The protein is a multifunctional
type II transmembrane protein with roles in ribosomal transcription,
cell attachment, tumor metastasis formation and functions as a
receptor for various viruses (for review: [20]). LRP/LR acts as a cell
surface receptor for PrPc [21] and for infectious prions [22,23]. Re-
cently, several approaches for prion disease therapy targeting LRP/LR
have been described (for review: [20,24,25]. These include (i)
antibodies directed against the 37 kDa/67 kDa LRP/LR [26,27], (ii)
siRNAs targeting the 37 kDa LRP mRNA [28] (Ludewigs et al., in
preparation), (iii) transdominant negative LRP/LR mutants acting as a
decoy [29] and (iv) polysulfated glycanes [22]. Blocking or down-
regulation of LRP/LR by these molecular tools reduced invasion of
tumorigenic ﬁbrosarcoma cells (HT1080) recommending these mole-
cules as alternative therapeutics for prevention of cancer metastasis
and tumor progression [30]. In the present study, we used both
ﬂuorescence-coupled PrPc and LRP/LR to visualize both proteins after
transfection in eukaryotic cells. We generated cyan ﬂuorescent LRP
(LRP-ECFP), red ﬂuorescent LRP (LRP-DsRed) and green ﬂuorescent
LRP (LRP-EGFP), respectively, as well as a red ﬂuorescent prion protein
mutant lacking its signal peptide (DsRed-ΔSP-PrP). In addition, we
used full-length prion protein coupled to the green ﬂuorescent protein
(PrP-EGFP) [17]. Here, we describe the subcellular localization of these
proteins after transient transfection in two different cell lines
employing confocal immunoﬂuorescence (IF) microscopy. We conﬁrm
that PrP-EGFP is localized in a perinuclear compartment and on the
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into the nucleus without colocalization with heterochromatin. Addi-
tionally, we observe a colocalization of LRP-DsRed and EGFP-PrP in the
perinuclear compartment and a partly colocalization of LRP-ECFP and
DsRed-ΔSP-PrP in the nucleus suggesting a potential role of PrPc in
gene regulation.
2. Material and methods
2.1. Plasmid constructions
For the generation of the plasmid pDsRed-ΔSP-PrP, the coding sequence for DsRed
was ampliﬁed from the plasmid pDsRed-Express-N1 (Clonetech) using the oligonu-
cleotides 5′-AgeI-DsRed (5′-GTCAAACCGGTCGCCACCATGGC-3′) and 3′-BglII-DsRed (5′-
GTCAAAGATCTCA GGAACAGGTGGTGGCG-3′) and subsequently inserted into the target
vector pEGFP-PrP [17] using the restriction sites AgeI and BglII. The plasmid pLRP-DsRed
was cloned by inserting the murine laminin receptor coding sequence (ampliﬁed from
pSFV1-moLRP::FLAG [22]) into the target vector pDsRed-Express-N1 (Clonetech) by use
of BamHI- and SmaI-coding oligonucleotides 5′-BamHI-LRP and 3′-SmaI-LRP (5′-GTCA-
AGGATCCGCCACCCATGTCC-3′, 5′-GTCAACCCGGGGCCACCATGTCCGGAGCC-3′). The
plasmid pLRP-EGFP was generated by insertion of the LRP cassette ampliﬁed from
pSFV1-moLRP::FLAG using the oligonucleotides 5′-XmaI-LRP (5′-GTCAACCCGGGCCAC-
CATGTCCGGAGCC-3′) and 3′-BamHI-moLRP (5′-GTCAAGGGATCCGGACCACTCAGTGGT-
GGC-3′) into the plasmid pEGFP-N3. The vector pLRP-ECFP was cloned in two steps.
First, pECFP-N1 plasmid was generated via exchange of DsRed with the ECFP cassette
ampliﬁed from pECFP-Endo vector (Clonetech) with the primers 5′-AgeI-ECFP (5′-
GTCAAACCGGTCGCCACCATGGTG-3′) and 3′-NotI-ECFP (5′-GTCCAGCGGCCGCTACTTG-
TACAGCTCGTCCATG-3′) and subsequent insertion into pDsRed-Express-N1 vector. In
the second step, the murine LRP sequence was inserted into the newly generated vector
pECFP-N1 by restriction of the pLRP-DsRed plasmid using the restriction enzymes XmaI
and AgeI. All generated plasmid sequences were veriﬁed by dideoxy sequencing.
2.2. Cell culture and transfections
Baby hamster kidney (BHK, ATCC CCL-10) and murine neuroblastoma cells (N2a,
ATCC CCL-131) were cultivated in DMEM (Invitrogen) supplemented with 10% fetal calf
serum (Invitrogen) and 1% non-essential amino acids. For calcium phosphate transfection,
cells were plated at 30% conﬂuency in 6 well plates prepared to contain one coverslip
per well and were incubated overnight to enable cell attachment. In total, 8 µg of mixed
plasmids plus 9 µl (2.5 M) calcium chloride completed to 90 µl with ultrapure water was
prepared. Next, 90 µl of sterile ﬁltered HBS buffer (sodium chloride 281 mM, HEPES
100 mM, sodium phosphate 1.5 mM, pH 7.12) was added while plasmids were vortexed
for 1 min and precipitates were added onto the cells containing 25 µM chloroquin in
DMEM. Media were changed once after 8 h and a second time after overnight
incubation. Transfection experiments were carried out in three individual experiments.Fig. 1. Expression of the PrP fusion proteins and the 37 kDa/67 kDa laminin receptor in ma
transfected into BHK cells to investigate the subcellular localization of PrP and LRP/LR, respec
cDNA encoding amino acids 23–254 C-terminally to EGFP and DsRed. The sequence of muri
Expression of PrP derived fusion proteins was analyzed 48 h post transfection (left panel). Bo
(lane 3) were detected using the PrP-speciﬁc mAb SAF 32. Expression of LRP derived fusion p
cell lysate (lane 1) and LRP-DsRed derived cell lysate (lane 3) were compared to mock-tran2.3. Western blot analyses
48 h after transfection, cells were detached by trypsin (0.1% in PBS) lysed in 50 µl
lysis buffer (10 mM Tris/HCl pH 7.5, 100 mMNaCl, 10 mM EDTA, 0,5% Nonidet P-40, 0,5%
Desoxycholate) and incubated on ice for 30 min. Samples were centrifuged at
14,000 rpm in an Eppifuge (Heraeus) and supernatant was mixed with SDS sample
buffer. Samples were boiled at 95 °C for 5 min and subjected to SDS polyacrylamide gel
electrophoresis using a 12% separation gel. Samples were blotted on nitrocellulose
membranes and blocked by horse serum (20% in PBS) followed by incubation with
either anti-PrP antibody SAF 32 (1:5000) [31] or anti-LRP antibody W3 (1:5000) [21].
Blots were then incubated with the secondary anti-mouse and anti-rabbit HRP
conjugated antibody (Sigma) (1:5000), respectively, following detection using Super-
Signal detection kit (Pierce).
2.4. Immune ﬂuorescence and confocal microscopy
24–48 h post transfection cells were ﬁxed using 4% paraformaldehyde for 20 min at
room temperature and were stained by 10 µg per ml DAPI for 10 min at room
temperature. After threefold PBS wash cells were embedded using confocal matrix
(MicroTechlab). The confocal analyses were carried out on a Leica DM IRE2 confocal
microscope using the Leica confocal software TCS SP2 version 2.5.
3. Results
3.1. Cloning and expression of the ﬂuorescence labeled prion protein and
the 37 kDa/67 kDa laminin receptor
The ﬂuorescent fusion proteins were generated on the basis of
pEGFP-N1 and pDsRed-N1 as well as pECFP-C1 and pDsRed-C1 vector
backbones, respectively. The insertion resulted in ﬂuorescence-coupled
variants of the mouse prion protein and the murine laminin receptor
fusion proteins (Fig.1A). The enhanced green ﬂuorescent protein (EGFP)
was placed in frame between the prion protein-derived signal peptide
[9] to obtain the EGFP-PrP fusion protein. The variant lacking the signal
peptidewas fused to theC-terminus of theDsRed sequence (DsRed-ΔSP-
PrP). In case of the laminin receptor (LRP/LR) fusion proteins, the
ﬂuorescent proteinswere fused in frame to theC-terminal endof LRP/LR
to obtain LRP-ECFP, LRP-DsRed and LRP-EGFP, respectively. The expres-
sion of the prion protein fusion protein variants EGFP-PrP and DsRed-
ΔSP-PrP in BHK cells was conﬁrmed by Western blotting showing that
both proteins were present in cell lysates (Fig. 1B, left panel, lanes 1, 2).
The EGFP-PrP was typically glycosylated showing a three band patternmmalian cells. (A) Fluorescent gene fusion constructs were generated and transiently
tively. The cDNA for the signal peptide (SP) of murine PrPc was cloned N-terminally, the
ne LRP was cloned N-terminally to the ECFP, DsRed and EGFP proteins, respectively. (B)
th EGFP-PrP (lane 1) and DsRed-DSP-PrP (lane 2) in comparison to non-transfected cells
roteins was analyzed in BHK cells 48 h post transfection (right panel). LRP-ECFP derived
sfected cells (lanes 2, 4, 6) using the polyclonal anti-LRP serum W3.
Fig. 2. Localization of green ﬂuorescent protein coupled prion protein (EGFP-PrP) in a perinuclear compartment. (A) EGFP-PrP was examined 48 h post transfection in BHK cells using
confocal microscopy. (B) Co-staining of the nucleic laminawith a lamin B-speciﬁc antibody followed by incubationwith a secondary antibody conjugatedwith indocarbocyanine Cy3.
(C) Merge of A and B. The bar represents 4 µm.
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variant lacking the signal peptidewas unglycosylated (Fig.1B, left panel,
lane 2). The increased molecular weight of the PrP proteins resulted
from the EGFP fusion that has a molecular weight of approximatelyFig. 3. The prion protein mutant DsRed-ΔΔSP-PrP does not colocalize with heterochromat
analyzed by confocal microscopy. Z sections through an individual cell were performed vary
simultaneously stained by DAPI (10 µg/ml) and analyzed for heterochromatin/DNA staining, r
with DsRed-ΔSP-PrP and analyzed by confocal microscopy. (E) Simultaneously, the same cell
the EGFP channel for better visualization. (F) Channels were merged. The bar represents 8 µ35 kDa. Moreover, the speciﬁcity of the antibody stain was conﬁrmed
using non-transfected control cell lysate (Fig. 1B, left panel, lane 3).
In addition, the expression of the LRP/LR fusion proteins LRP-ECFP
(Fig. 1B, right panel, lane 1), LRP-DsRed (Fig. 1B, right panel, lane 5) andin in the nucleus. (A) N2a cells were transiently transfected with DsRed-ΔSP-PrP and
ing about 2.8 µm in the z plane in total (individual steps 0.2 µm). (B) The same cell was
espectively. (C) Merge of A and B. The bar represents 6 µm. (D) N2a cells were transfected
was stained with DAPI (10 µg/ml) and analyzed for heterochromatin/DNA staining using
m.
Fig. 4. Colocalization of the 37 kDa/67 kDa laminin receptor (LRP/LR) with green ﬂuorescent protein coupled prion protein (EGFP-PrP) and in part-colocalization with the mutant
prion protein DsRed-ΔSP-PrP. (A) BHK cells were transiently cotransfected with pEGFP-PrP and pLRP-DsRed. 48 h post transfection cells were ﬁxed and the distribution of ﬂuorescent
proteins was analyzed by confocal microscopy. Green channel (left pannel), red channel (middle pannel) and merge (right pannel). (B) BHK cells were transiently cotransfected with
pDsRed-ΔSP-PrP and pLRP-ECFP. 48 h post transfection cells were ﬁxed and the distribution of ﬂuorescent proteins was analyzed by confocal microscopy. Red channel (left pannel),
blue channel (middle pannel) and merge (right pannel). The bar represents 20 µm.
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employing the polyclonal LRP antibody W3 [25,32].
3.2. EGFP-PrP accumulates in the perinuclear compartment
EGFP-PrP was transfected into BHK cells and subcellular localization
was examined 24 h post transfection by confocal ﬂuorescence mic-
roscopy. In cells expressing high levels of the transgene an accumulation
of EGFP-PrP inanendosomal compartment (Fig. 2A)whichwas localized
in closeproximity to thenucleuswas observed (Fig. 2B, C). Thisﬁnding is
supported by previous publications demonstrating that EGFP-PrP is
localized in eitherGolgi compartments or, after internalization of PrPc, in
endosomal compartments including an accumulation in the perinuclear
compartment [16,17].
3.3. DsRed-ΔSP-PrP is localized in the nucleus and does not colocalize
with heterochromatin
Themutant PrP DsRed-ΔSP-PrP lacking the signal peptide revealed
a distinct localization pattern (Fig. 2B) in neuronal cells (N2a). The
mutant PrP variant did not colocalize with EGFP-PrP (data not shown)
andwas localized in the nucleus andnot in the cytoplasm (Fig. 3 A). The
nucleic localization of PrP lacking its signal peptide has been reported
previously in a study using antibody-based ﬂuorescent-staining [18].
Here, we conﬁrm this ﬁnding by transient transfection of DsRed-ΔSP-
PrP in BHK cells (data not shown) in addition to N2a cells (Fig. 3).
However, upon co-staining of the DNA with DAPI (Fig. 3B, E) no
colocalization of red ﬂuorescent DsRed-ΔSP-PrP and the heterochro-
matin (Fig. 3C)was detected. Due to the indistinct analysis of themerge
of the blue DAPI stain and the red ﬂuorescence of DsRed-ΔSP-PrP, the
ﬁlter of the confocal microscope was changed from blue to green for
the visualization of DAPI (Fig. 3E, F). Our ﬁnding implicates that the
herein used DsRed-ΔSP-PrP does not colocalize with heterochromatin.
3.4. The 37 kDa/67 kDa laminin receptor colocalizes with EGFP-PrP and
partly colocalizes with DsRed-ΔSP-PrP in the nucleus
Furthermore, we investigated the distribution of the 37 kDa/67 kDa
laminin receptor (LRP/LR) upon cotransfection using the different PrPvariants. Cotransfection of EGFP-PrP and LRP-DsRed resulted in a
colocalization in the perinuclear compartment and on the cell surface
(Fig. 4A). In earlier studieswe showed that PrPc and LRP/LR colocalize on
the cell surface of neuroblastoma cells [21]. In addition, LRP-ECFP also
localized in the nucleus of cotransfected DsRed-ΔSP-PrP cells. This
ﬁnding argues that upon expression of the PrP mutant, LRP/LR was
partly directed to or localized to the nucleus (Fig. 4B) and not localizing
within the perinuclear compartment. Previously, it has been shown that
LRP/LR iswidely spread through all cellular compartments including the
cytoplasm, the nucleus and the cell surface where it contributes to its
multifunctional role in cell biology [33–35]. Although a typical colo-
calizationpatternwasnot observed,we found that LRP-ECFPandDsRed-
ΔSP-PrP were partly colocalized in the nucleus (Fig. 4B).
4. Discussion
4.1. Putative role of the prion protein mutant DsRed-ΔSP-PrP in the
nucleus
The eukaryotic cell nucleus is organized within subnuclear com-
partments including the nucleic envelope, the eu- and heterochroma-
tin aswell as the nucleoli as sites of ribosomeproduction and assembly.
A variety of proteins are localized in the nucleus and are part of the
ribosomal, replication or transcription machinery and the spliceo-
some, respectively. However, a putative role of a prion protein located
in the nucleus, in case its signal peptide is genetically removed, is
highly speculative. So far, there is no evidence that PrP lacking its signal
peptide is present in the nucleus under physiological conditions.
Nevertheless, the nuclear localization of DsRed-ΔSP-PrP is astonishing.
As it was previously discussed, there is no evidence, that a nuclear
localization signal is responsible for such action [18]. Until now it is
speculative how PrP in the absence of its signal peptide targets the
nucleus. Further analyses are required to unveil this mode of action.
4.2. The 37 kDa/67 kDa laminin receptor and the prion protein colocalize
intracellularly
In the present report, we show for the ﬁrst time the intracellular
colocalization of LRP/LR with PrP. We hypothesize that the nucleic
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via an interaction with another protein. Such an interaction partner
might be the 37 kDa/67 kDa laminin receptor LRP/LR which has been
identiﬁed as the cell surface receptor for the cellular PrP and infectious
prions [21–23]. To investigate this possibility, we generated ﬂuores-
cent LRP variants,whichwere used for colocalization studieswith both
EGFP-PrP and DsRed-ΔSP-PrP. Our results are consistent with thewide
cellular localization pattern of LRP-EGFP including the nucleus, the
cytoplasm and the cell surface. Previously, it has been reported that
LRP/LR, which is basically identical with the ribosomal protein p40
playing an important role in the translationprocess, is transported into
the nucleus under specialized conditions [36]. It has further been
shown that LRP/LR is located inside the nucleus, beside cytoplasmic
and cell surface localization, where it binds to histones [34,35]. Further
experiments are required to enlighten the unknown mechanism by
which cytoplasmic PrP variants are targeted to the nucleus.
Since internal nuclear localization signals are not involved in
nucleic import of the prion protein lacking the signal peptide [18], an
alternative way of nuclear import may involve an adapter protein that
contains a nuclear localization signal. It has been shown that the
37 kDa LRP is directed to the cellular nucleus after addition of midkine,
a heparin binding growth factor [36,37]. According to the binding
ability of PrP to LRP [21,38], we speculate that the nuclear localization
of the PrP variant DsRed-ΔSP-PrPmight be also dependent onmidkine.
This explanation, as well as the multifunctional role of LRP/LR in the
cell, may account for our ﬁnding that depletion of LRP/LR does not
totally impede nucleic transport of the mutant PrP. This issue shall be
further addressed in cell biology studies to unravel the yet unidentiﬁed
mode of action by which mutant PrP is transported into the nucleus.
4.3. Subcellular Localization of the mutant prion protein lacking the
signal peptide
Previously, Crozet et al. described a chromatin association for the
prion protein lacking its signal peptide [18]. However, the chromatin-
removal method has some limitations which might not reveal reliable
information on localization in vivo [39]. Here, we performed an
additional colocalization experiment by the use of the DNA stain DAPI
to conﬁrm the chromatin association of mutant PrP. Astonishingly, we
could barely ﬁnd a colocalization of DAPI stained DNA with DsRed-
ΔSP-PrP. This ﬁnding clearly argues against a tight chromatin binding
of DsRed-ΔSP-PrP, because the distance of two molecules lacking
colocalization clearly exceeds 200 nm in the x/y plane and even more
than 400 nm in the z plane. The mutant protein is found in nucleic
compartments containing a low DNA content, which may be nucleoli
structures. Therefore, further experiments, in which subnuclear
structures are speciﬁcally co-stained will be needed to investigate
the subnuclear localization of DsRed-ΔSP-PrP.
In summary,we have conﬁrmed, that EGFP-PrP is localized at the cell
surface and in a perinuclear compartment within the cell and that
mutant DsRed-ΔSP-PrP localized to the nucleus. Interestingly, we found
that the latter PrP mutant failed to be colocalized with DAPI stained
heterochromatin. Furthermore, in the present study we showed for the
ﬁrst time that (i) PrP-EGFP and LRP-DsRed colocalize in the perinuclear
compartment in addition to a cell surface-colocalization and (ii) DsRed-
ΔSP-PrP and LRP-ECFP partly colocalize in the nucleus, respectively.
Thus, the 37 kDa/67 kDa LRP/LR and the prion protein reveal close
proximity not only on the surface of eukaryotic cells but additionally in
intracellular compartments. Investigations by immunoprecipitation or
cellular fractionationwill furtherunravel the role of PrP, PrPmutants and
LRP/LR in the life cycle of prions.
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